TAMPA, Fla., Dec. 30, 2013 /PRNewswire/ — Whistleblower Law Firm, P.L. is pleased to announce that the qui tam lawsuit originally brought and filed by its managing member, Natalie Khawam, Esq., MBA, MS, in the matter of United States ex rel Fuentes et.al. v. Genzyme Corporation, No. 8:09-cv-1245-T-23-EAJ, U.S. District Court for the Middle District of Florida, was settled on December 20, 2013 for $22.28 million.
"I am pleased to see the case I developed come to a successful conclusion," said Natalie Khawam, Managing Member of Whistleblower Law Firm, P.L.
Attorney Natalie Khawam identified, prepared and filed this qui tam suit, while associated with the law firm of Cohen, Foster & Romine, in 2009, on behalf of two sales representatives of Genzyme who alleged that Genzyme encouraged them to market a surgical substance called Seprafilm for uses not approved by the FDA. The suit alleged that false claims were made for such uses under Medicare and Medicaid. On December 20, 2013, the Department of Justice announced that the suit has been settled with Genzyme agreeing to pay a total of $22.28 million to the United States and a group of states in settlement of the claims.
About Natalie Khawam and the Whistleblower Law Firm
Attorney Natalie Khawam is a graduate of Georgetown University Law Center, and earned an MBA degree and an M.S. degree in healthcare prior to her achieving her law degree. Ms. Khawam has significant experience in healthcare law, including having worked in the Office of the General Counsel, at the U.S. Department of Health & Human Services, for the Centers for Medicare and Medicaid Services (CMS) division.
The Whistleblower Law Firm, P.L. is located in downtown Tampa, FL, in the BB&T building. For more information about the firm, please call (813) WHISTLE.